Skip to content
Parakho

Dr. Lal PathLabs Ltd

NSE LALPATHLABBSE 539524

Q1 FY27, unaudited

Revenue
₹764.40 Cr
Profit after tax
₹165.90 Cr

As filed with the exchange, standalone basis.

Board meeting

Dr. Lal PathLabs Ltd has given BSE notice of a board meeting on 04 Nov 2026 to consider Q2 FY27 results. Notice · Results calendar

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations764.40+19.31%2,647.60
Other income29.90+13.69%112.70
Total income794.30+19.09%2,760.30
Employee benefit expense125.00−0.64%475.20
Finance costs6.10+35.56%22.00
Depreciation & amortisation40.00+21.95%154.10
Total expenses572.00+15.65%2,070.00
Profit before tax222.30+28.94%660.20
Tax expense56.40+30.86%152.00
Profit after tax165.90+28.31%508.20
Total comprehensive income167.20+30.22%513.20
Earnings per share
Earnings per share, basic₹9.94₹30.45
Earnings per share, diluted₹9.92₹30.40

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Q1 FY27 results for every company Parakho holds

Earnings call

Q1 FY27

Dr Lal PathLabs reported Q1 FY27 revenue of Rs. 798 crore, up 19.1% year-on-year, driven by patient volume growth of 8.2% and sample volume growth of 10.7%. EBITDA rose 28.7% to Rs. 247 crore with a margin of 31.0%, while profit after tax grew 27.2% to Rs. 170 crore. Management attributed part of the realization growth to CGHS/ECHS price increases and discussed rural outreach expansion, international ventures in Dubai and Ghana, and continued investment in scientific and digital initiatives.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote.

Read the full summary

Earlier calls: Q4 FY26 · All quarters

Filings

12 shown · 64 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Healthcare › Healthcare Service Provider

Classification as published by BSE.

Companies also in Healthcare Service Provider, in alphabetical order

All 32 companies in Healthcare Service Provider

Page generated from filings held to 12 Oct 2026.